[Skip to Content]

Patient Enrollment

  • IDS will communicate with the investigator or study coordinator to ensure that patient enrollment, drug dispensing, and drug administration are consistent with the protocol.
  • Randomization of the patient to determine the correct drug and treatment regimen will occur promptly. The IDS can develop a patient randomization schedule if one is not provided in the study protocol.
  • Preparation of doses as described in the protocol. All study drugs are packaged to maintain blinding when required and to promote safe administration.